Levodopa Therapy:Why Wait? Patient Care June 15
1971., , 1971
Manic Response to Levodopa Therapy
NEJM 285:788, Ryback,R.,et al, 1971
Supranuclear Abnorm. of the Vert. Ocular Motor Syst
Trans Ophth United King 90:433, Sanders,M.D.,et al, 1970
Monoamine Oxidase Inhibitor & L-Dopa
BMJ 3:388, Hunter,H.R.,et al, 1970
Diseases of the Extrapyramidal System
Disease-a-month-Jan 1970., Klawans,H.,et al, 1970
Controlled Trial of Amantadine Hydrocloride in Parkinson's Disease
Lancet 259, Feb1970., Parkes,J.D., 1970
L-Dopa in the Treatment of Parkinson's Disease
Postgrad Med 47:153, Martin,W., 1970
Dopamine & Disease
C M A Journ 103:824, Barbeau,A., 1970
Progressive Supranuclear Palsy Clinico-Pathological Study of Four Cases
Brain 92:663, Behrman,S.,et al, 1969
Amantadine in the Treatment of Parkinson s Disease
JAMA 208:1168, Schwab,R.,et al, 1969
Pituitary Tumors
Hosp Med Jun 1969, P. 90., Rovit,R., 1969
Stereotaxic Radiofrequency Surgery of the Normal & Abnormal Pituitary Gland
NEJM 280:429, Zervas,N., 1969
Neuropsychopharmcology & the Affective Disorders
NEJM 281:197, 1969 (three parts) ., Schildkraut,J.J., 1969
Function of the Basal Ganglia
Handbook of Clinical Neurology 6:90-115, Ward,A., 1968
Degen. & Exog. Lesions of the Pallidum & Striatum
In:Vinker P. J. , Bruyn G. W. eds. Handbook of Clin Neurol Vol. 6 Amsterdam:N. Holland Publ 1968:672, ellinger,D., 1968
Corticodentatonigral Degeneration with Neuronal Achromasia
Arch Neurol 18:20-33, Rebeiz,J.J.,et al, 1968
Parkinson's Disease
In Handbk of Clinical Neurology, Vinken, P. J. & Bruyn, G. W. , Ed, North-Holland Publ Co, Amsterdam, 6:173, 1968. Selby, G., 1968
Clinical Cases-Dx:Functional Approach to Neuroanatomy pp 477-490 Earl Lawrence House
McGraw Hill 1967., , 1967
Neurologic Complications of Polycythemia
Ann Int Med 57:909, Silverstein,A.,et al, 1962
Diseases of the Basal Ganglia-Their Relation to Disorders of Movement
Lancet 1099, 1960, Nov., Denny-Brown,D., 1960
An 81-Year-Old Man with Imbalance and Memory Impairment
, Golbe,L.I.,et al,